LIN Mao 1,2,3,4 , YANG Chunsong 2,3,4 , CHENG Xiao 1,2,3,4 , QIU Jiayu 2,3,4 , ZHANG Lingli 2,3,4
  • 1. West China School of Pharmacy, Sichuan University, Chengdu, 610041, P.R.China;
  • 2. Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, 610041, P.R.China;
  • 3. Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, 610041, P.R.China;
  • 4. Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, 610041, P.R.China;
ZHANG Lingli, Email: zhanglingli@scu.edu.cn
Biomedicine; Literature analysis; Study type
10.7507/1672-2531.201810099
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objectives To evaluate the level and variation of Chinese scholars' scientific research capability in the world by analysing the status of literature published on top-five global biomedicine journals by Chinese scholars in the past 10 years.Methods Literature published on NEJM, JAMA, BMJ, Lancet and PLoS Medicine from 2007 to 2016 were searched in PubMed database. Types of diseases were classified by using International Classification of Diseases (version 10) (ICD-10). Quantitatively analysis were used to classify the different authors, institutes, studies designs, quality of publication and variation.Results Literature (56.4%) published on Lancet had the largest quantity among the top-five journals. Infectious and parasitic diseases, circulation system diseases, cancers, endocrine, nutrition and metabolic diseases and neuropsychiatric diseases were the top-five in disease categories list, accounting for 38.4%. In different study design, reviews (non-experimental research) and randomized controlled trials were the first and the second study types, separately.Conclusions For productivity of Chinese scholars’ diseases publications on top-five medical journals, the top-five specific diseases are from the top-five disease categories-infectious and parasitic diseases, circulation system diseases, cancer, endocrine, nutrition and metabolic diseases and neuropsychiatric diseases. The main study types are reviews, randomized controlled trials and cross-sectional studies.

Citation： LIN Mao, YANG Chunsong, CHENG Xiao, QIU Jiayu, ZHANG Lingli. Literature analysis on the Chinese scholars’ publications on top-five global biomedicine journals: from 2007 to 2016. Chinese Journal of Evidence-Based Medicine, 2019, 19(7): 851-855. doi: 10.7507/1672-2531.201810099 Copy

  • Previous Article

    Instruments designed for quality assessment of pharmaceutical economic evaluations: an overview

  • Next Article

    Evidence-based evaluation of global value assessment tools